Microalbuminuria, blood pressure, metabolic control, and renal involvement: Longitudinal studies in white non-insulin-dependent diabetic patients

American Journal of Hypertension

Volumn 10, Issue 9 SUPPL. 1, 1997, Pages 189S-197S

  Schmitz, Anita ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HORSENS REGIONAL HOSPITAL   (Denmark)

Author keywords

Microalbuminuria; Non diabetics; Non insulin dependent diabetes mellitus; Normal albumin excretion; Renal function; Risk factors

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

ALBUMINURIA; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; LONGITUDINAL STUDIES; RISK FACTORS;

EID: 0030760342     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(97)00152-0     Document Type: Article

References (58)

1. Mogensen CE, Chachati A, Christensen CK, et al: Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985-86;9:85-95.
2. Eshøj O, Feldt-Rasmussen B, Larsen ML, Mogensen EF: Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria. Diabetic Med 1987;4:531-533.
3. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93.
4. Viberti GC, Hill RD, Jarrett RJ. et al: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;i:1430-1432.
5. Parving H-H, Oxenbøll B, Svendsen PA, et al: Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982;100:550-555.
6. Mathiesen ER, Oxenbøll B, Johansen K, et al: Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984;26:406-410.
7. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-360.
8. Jarrett RJ, Viberti GC, Argyropoulos A, et al: Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1984;1:17-19.
9. Schmitz A, Væth M: Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Med 1988;5:126-134.
10. Mattock MB, Morrish NJ, Viberti GC, et al: G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992;41:736-741.
11. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE: Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 1992;41: 731-735.
12. Neil A, Hawkins M, Potok M, et al: A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993;16: 996-1003.
13. Uusitupa MIJ, Niskanen LK, Siitonen O, et al: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993;36:1175-1184.
14. Gall M-A, Borch-Johnsen K, Hougaard P, et al: Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995;44:1303-1309.
15. MacLeod JM, Lutale J, Marshall SM: Albumin excretion and vascular deaths in NIDDM. Diabetologia 1995;38: 610-616.
16. Fabre J, Balant LP, Dayer PG, et al: The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int 1982;21:730-738.
17. Gall M-A, Rossing P, Skøtt P, Damsbo P, et al: Prevalence of micro- and microalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991;34:655-661.
18. Marshall SM, Alberti KGMM: Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Q J Med 1989;70(261):61-71.
19. Olivarius N. de F, Andreasen AH, Keiding N, Mogensen CE: Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes care in general practice," Denmark. Diabetologia 1993;36:1007-1016.
20. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988;ii:530-533.
21. Jensen JS: The distribution of urinary albumin excretion and its association to atherosclerotic risk factors. A cross-sectional study of 2613 individuals. PhD; Faculty of Health Sciences, Denmark, The University of Copenhagen, 1996.
22. Feldt-Rasmussen B, Borch-Johnsen K, Deckert T, et al: Microalbuminuria: an important diagnostic tool. J Diabetic Compl 1994;8:137-145.
23. Schmitz A: The kidney in non-insulin-dependent diabetes. Studies on glomerular structure and function and the relationship between microalbuminuria and mortality (thesis). Acta Diabetol 1992;29:47-69.
24. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B: Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis 1995;112:245-252.
25. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B: Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci 1995;88:629-633.
26. Nannipieri M, Rizzo L, Rapuano A, et al: Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care 1995;18:1-9.
27. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
28. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994;43:960-967.
29. Mykkänen L, Haffner SM, Kuusisto J, et al: Microalbuminuria precedes the development of NIDDM. Diabetes 1994;43:552-557.
30. Schmitz A: Nephropathy in non-insulin-dependent diabetes mellitus and perspectives for intervention. Diabetic Nutr Metab 1995;7:135-148.
31. Schmitz A, Christensen T, Møller A, Mogensen CE: Kidney function and cardiovascular risk factors in non-insulin-dependent diabetics (NIDDM) with microalbuminuria. J Intern Med 1990;228:347-352.
32. Nielsen S, Schmitz A, Rehling M, Mogensen CE: The clinical course of renal function in NIDDM patients with normo- and microalbuminuria. J Intern Med 1997; 241:133-141.
33. Nielsen S, Schmitz A, Rehling M, Morgensen CE: Systolic blood pressure relates to the rate of decline of glomerular filtration rate in type II diabetes. Diabetes Care 1993;16:1427-1432.
34. Gall M-A, Nielsen FS, Smidt UM, Parving H-H: The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 1993;36:1071-1078.
35. Østerby R, Gall M-A, Schmitz A, et al: Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993;36: 1064-1070.
36. Schmitz A, Gundersen HJG, Østerby R: Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Lack of glomerular hypertrophy. Diabetes 1988;37:38-43.
37. Suarez L, Barrett-Connor E: Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol 1984;120:670-675.
38. Morrish NJ, Stevens LK, Head J, et al: A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics). II: Associated risk factors. Diabetologia 1990;33:542-548.
39. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L: Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. Br Med J 1989;299: 1127-1131.
40. Fitzgerald AP, Jarrett RJ: Are conventional risk factors for mortality relevant in type 2 diabetes? Diabetic Med 1991;8:475-480.
41. Fuller JH, Head J, WHO Multinational Study Group: Blood pressure, proteinuria and their relationship with circulatory mortality: the WHO multinational study of vascular disease in diabetics. Diabete Metab (Paris) 1989;15:273-277.
42. Coppack SW, Doll HA, Pim B, Hockaday TDR: Intravenous glucose tolerance and mortality in non-insulin-dependent diabetes mellitus. Q J Med 1990;75(277):451-460.
43. Christensen CK. The preproteinuric phase of diabetic nephropathy (thesis). Copenhagen, Denmark, Lægeforeningen, 1991.
44. Schmitz A, Væth M, Mogensen CE: Systolic blood pressure relates to the rate of progression of albuminuria in non-insulin-dependent diabetes. Diabetologia 1994;37: 1251-1258.
45. Schmitz A, Mau Pedersen M, Hansen KW: Blood pressure by 24 h ambulatory recordings in type 2 (non-insulin dependent) diabetics. Relationship to urinary albumin excretion. Diabete Metab (Paris) 1991;17:301-307.
46. Baba T, Murabayashi S, Takebe K: Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial. Diabetologia 1989;32:40-44.
47. Melbourne Diabetic Nephropathy Study Group: Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 1991;302:210-216.
48. Lacourcière Y, Nadeau A, Poirier L, Trancrède G: Captopril or conventional therapy in hypertensive type II diabetics. Three year analysis. Hypertension 1993;21: 786-794.
49. McNally PG, Cooper ME: Antihypertensive treatment in NIDDM, with special reference to abnormal albuminuria, in Mogensen CE (ed): The Kidney and Hypertension in Diabetes Mellitus, ed 2. Kluwer Academic Publishers, Boston, 1994, pp 341-351.
50. Ravid M, Lang R, Rachmani R, Lishner M: Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. Arch Intern Med 1996;156:286-289.
51. Klein R, Klein BEK, Moss SE: Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996;124:90-96.
52. Nathan DM: The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann Intern Med 1996;124:86-89.
53. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
54. Vedel P, Graade P, Obel J, et al: Intensive multifactorial intervention in NIDDM patients with persistent microalbuminuria. Diabetologia 1996;39(suppl 1):A282.
55. U.K. Prospective Study Group: U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II Diabetes: a progressive disease. Diabetes 1995;44:1249-1258.
56. Wolffenbuttel BHR, van Haeften TW: Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM). Drugs 1995;50:263-288.
57. Foote EF: Prevention and treatment of diabetic nephropathy. Am J Health Syst Pharm 1995;52:1781-1792.
58. Schmitz A: Microalbuminuria and mortality in non-insulin-dependent diabetes, in Mogensen CE (ed): The Kidney and Hypertension in Diabetes Mellitus. Kluwer Academic Publishers, Boston, 1988; pp 65-70.